Yan Fu

Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation

Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: interaction effect with disease severity—a retrospective study

Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression

Regulation and Function of the PD-L1 Checkpoint

Cisplatin: The first metal based anticancer drug

Cisplatin in cancer therapy: Molecular mechanisms of action

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Association of IL‐4 −590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population

Bevacizumab plus chemotherapy versus chemotherapy alone for preventing brain metastasis derived from advanced lung cancer

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion

Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer

Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population